Japanese Drug Companies Open Chemical Compound Libraries To DNDi In Effort To Improve NTD Therapies

New York Times: Japanese Companies Attack Neglected Diseases
“Several Japanese drug companies have joined a new project to find medicines to treat two neglected parasitic diseases, Chagas and leishmaniasis. Eisai Co., Shionogi & Co., and Takeda Pharmaceutical will join AstraZeneca, a London-based company, in opening their libraries of millions of chemical compounds to the Drugs for Neglected Diseases Initiative, allowing researchers to look for chemicals that kill the parasites in infected cells…” (McNeil, 6/1).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.